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ABSTRACT. 
We analyzed variations in the annual incidence of the main cardiovascular risk 
factors, prevalent chronic diseases, common mental health disorders and 
neoplasms in 2020 compared with 2017-2019. In 2020, there was a significant 
decrease in the incidence of hypertension, hypercholesterolemia, type 2 diabetes 
mellitus, chronic kidney disease, ischemic heart disease, benign prostatic 
hypertrophy, osteoporosis, hypothyroidism, chronic obstructive pulmonary disease, 
alcohol use disorder, benign tumors, and melanomas. Only anxiety disorders 
increased significantly (IRR 1.16; 95% CI 1.07-1.24). Prioritization of COVID-19 
care has changed the doctor-patient relationship to the detriment of face-to-face 
scheduled visits of chronic disease detection and monitoring protocols. 
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INTRODUCTION. 
The SARS-CoV-2 coronavirus pandemic has placed unprecedented stress on 
health systems. In Spain, with a total of 2,883,465 confirmed cases and 60,370 
deaths (1), it has led to radical changes in primary care medicine and nursing. 
Primary care centers have detected > 80% of all cases and have redirected their 
efforts to the prevention, diagnosis and monitoring of COVID-19 cases and their 
contacts (2). They have also responsible for the early detection of complications 
and mass testing of vulnerable patients in nursing homes and schools. The 
prioritization of COVID-19 care has changed the doctor-patient relationship through 
widespread use of teleconsultations, email consults, and telemonitoring to avoid 
face-to-face care and minimize the risk of contagion (3). However, COVID-19 
preventive measures (especially home confinement, curfews, and physical 
distancing), the fear of contagion and the transformation of family medicine 
services to respond to COVID-19 may have led to significant reductions in the care 
of chronic noncommunicable diseases and cancer (4,5). We aimed to assess the 
impact of the prioritization of care for COVID-19 patients on the detection and 
diagnosis of the main cardiovascular risk factors, prevalent chronic diseases 
(including mental health problems) and neoplastic diseases in 2020 compared with 
2017-2019. 
METHODS. 
We made a retrospective, longitudinal study of variations in the annual incidence of 
the detection and diagnosis of the main cardiovascular risk factors, prevalent 
4 
This article is a preprint and has not been peer reviewed. It reports new medical research or thought that has yet to be evaluated and 
so should not be used to guide clinical practice. Copyright ©2021 by Antoni Sisó Almirall. Posted on Annals of Family Medicine COVID-
19 Collection, courtesy of Antoni Sisó Almirall. 
chronic diseases, frequent mental health disorders and neoplasms during 2017-
2020. Data came from a centralized database that records the frequency of the 
diagnoses studied in three primary care centers in Barcelona (Spain). In 2020, the 
assigned population aged >15 years in the three centers was 87,478 patients, with 
23.5% aged > 65 years. Diagnoses and health problems are recorded by 
physicians and nurses using the International Classification of Diseases (ICD-10). 
An SQL query system was used to obtain the aggregated frequency of the 
conditions studied. As data were anonymized, patient consent was not required, 
and the study was authorized by the Services Directorate. The annual incidence 
rates per 1000 patients were analyzed, and the incidence rate ratios (IRRs) were 
calculated to compare the incidence rate in 2020 with the mean of 2017-2019. The 
statistical analysis was made using R version 3.6.1. for Windows. 
RESULTS. 
In 2020, there were significant reductions in the incidence rates of hypertension 
(IRR 0.60, 95% CI 0.52-0. 68), hypercholesterolemia (IRR 0.64, 95% CI 0.57-0.72), 
type 2 diabetes mellitus (IRR 0.61, 95% CI 0.52-0.73), chronic kidney disease (IRR 
0.57, 95% CI 0. 48-0. 68), ischemic heart disease (IRR 0.52, 95% CI 0. 39-0. 68), 
benign prostatic hypertrophy (IRR 0.62, 95% CI 0.5 4-0.72), osteoporosis (IRR 
0.60, 95% CI 0.5 0-0.72), hypothyroidism (IRR 0.54, 95% CI 0. 46-0. 63), chronic 
obstructive pulmonary disease (IRR 0.50, 95% CI 0. 39-0. 65), alcohol use disorder 
(IRR 0.54, 95% CI 0. 38-0.77), benign tumors and colonic polyps (IRR 0.58, 95% 
CI 0. 49-0. 69) and melanomas (IRR 0.55, 95% CI 0.32-0.9 (2), compared with the 
5 
This article is a preprint and has not been peer reviewed. It reports new medical research or thought that has yet to be evaluated and 
so should not be used to guide clinical practice. Copyright ©2021 by Antoni Sisó Almirall. Posted on Annals of Family Medicine COVID-
19 Collection, courtesy of Antoni Sisó Almirall. 
mean in 2017-2019 (Table 1). The reductions ranged from 36% for 
hypercholesterolemia to 50% for chronic obstructive pulmonary disease. The 
incidence rates of heart failure, dementia, depression, renal cancer, and thyroid 
cancer were significantly lower than in the previous year. The only condition whose 
incidence significantly increased during 2020 relative to the mean incidence in 
2017-2019 was anxiety disorders (IRR 1.16, 95% CI 1.07-1.24). There was a non-
significant increase in the incidence of lung cancer. Figure 1 shows the trend of the 
annual incidence for each condition in the four years analyzed. 
DISCUSSION. 
Our results show a very significant decrease in the frequency of diagnoses of 
cardiovascular risk factors, chronic diseases, and some tumors in 2020 compared 
with 2017-2019, which can only be attributed to organizational changes in family 
medicine services aimed at prioritizing COVID-19 care. Other studies analyzing 
indicators of chronic disease follow-up reached similar conclusions during the first 
four months of the pandemic (6,7). The increased incidence of lung cancer, 
although non-significant, may be linked to the increase in pulmonary radiological 
tests (chest x-ray and chest CT) in the context of the pandemic.  
Between February and December 2020, primary care centers have been 
"bunkerized" and the new accessibility and proximity model, the loss of scheduled 
preventive and health promotion visits and the change from face-to-face visits to 
virtual consults to the reduction in incidence rates (8). Therefore, the minimization 
of face-to-face contact to protect against COVID-19 may have induced a 
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paradoxical contrary effect on the control of chronic disease. This effect might be 
further increased by the start of the COVID-19 vaccination campaign which is to be 
managed by primary care centers. The increase in anxiety disorders is also 
consistent with the current exceptional situation (9).  
In the immediate future, self-care and self-management health and disease, which 
largely depend on the knowledge, skills, and confidence of patients, must be 
reactivated. However, these isolated measures will be of little use without a plan to 
transform and strengthen primary care focused on increasing human resources, 
modernizing infrastructure, and generalizing telecommunications, if we are to 
regain control of chronic diseases and ensure a life expectancy similar to the pre-
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Table 1. Incidence rates (per 1000 persons) of cardiovascular diseases, chronic non-cardiovascular 
diseases, mental disorders, health problems and cancer diseases during the period from 2017 to 
2020. 
Diseases 2017 2018 2019 2020 IRR [95% CI]† IRR [95% CI]‡ 
Cardiovascular risk factors and diseases       
   Hypercholesterolemia 17.11 [15.88-18.42] 15.88 [14.72-17.11] 17.69 [16.47-18.97] 10.78 [9.86-11.77] 0.61 [0.54-0.68] 0.64 [0.57-0.72] 
   Hypertension 14.06 [12.96-15.22] 14.2 [13.11-15.34] 13.35 [12.31-14.46] 8.26 [7.46-9.12] 0.62 [0.54-0.70] 0.60 [0.52-0.68] 
   Type 2 diabetes 6.10 [5.46-6.81] 6.36 [5.71-7.06] 6.71 [6.05-7.42] 3.93 [3.44-4.47] 0.59 [0.50-0.69] 0.61 [0.52-0.73] 
   Chronic kidney disease 6.77 [6.10-7.48] 5.33 [4.75-5.96] 7.03 [6.37-7.75] 3.64 [3.18-4.15] 0.52 [0.44-0.61] 0.57 [0.48-0.68] 
   Heart failure 2.15 [1.79-2.57] 2.97 [2.54-3.44] 3.31 [2.87-3.81] 2.54 [2.16-2.96] 0.77 [0.62-0.95] 0.90 [0.72-1.12] 
   Stroke 1.86 [1.52-2.25] 2.22 [1.86-2.64] 1.74 [1.42-2.11] 1.86 [1.54-2.23] 1.07 [0.81-1.40] 0.96 [0.73-1.25] 
   Ischemic cardiomyopathy 3.24 [2.79-3.75] 2.23 [1.86-2.64] 2.24 [1.87-2.65] 1.32 [1.05-1.64] 0.59 [0.44-0.78] 0.52 [0.39-0.68] 
   Acute myocardial infarction 0.99 [0.75-1.29] 0.96 [0.72-1.24] 0.87 [0.65-1.14] 1.14 [0.89-1.44] 1.31 [0.91-1.91] 1.22 [0.84-1.76] 
Chronic non-cardiovascular diseases       
   Dementia 6.25 [5.60-6.95] 7.40 [6.71-8.14] 9.64 [8.85-10.47] 6.77 [6.13-7.45] 0.70 [0.62-0.80] 0.87 [0.76-1.00] 
   Asthma 5.34 [4.74-5.99] 6.86 [6.19-7.59] 5.68 [5.07-6.33] 5.07 [4.51-5.68] 0.89 [0.76-1.05] 0.85 [0.72-1.00] 
   Benign prostatic hypertrophy 9.00 [8.23-9.83] 9.23 [8.46-10.06] 8.25 [7.52-9.03] 5.47 [4.89-6.10] 0.66 [0.57-0.77] 0.62 [0.54-0.72] 
   Hypothyroidism/thyroiditis 7.39 [6.67-8.16] 7.32 [6.62-8.08] 7.92 [7.20-8.70] 4.07 [3.57-4.63] 0.51 [0.44-0.60] 0.54 [0.46-0.63] 
   Osteoporosis 5.83 [5.20-6.52] 4.92 [4.35-5.54] 5.76 [5.15-6.43] 3.31 [2.86-3.81] 0.57 [0.48-0.69] 0.60 [0.50-0.72] 
   Chronic obstructive pulmonary disease 2.73 [2.31-3.20] 2.75 [2.33-3.21] 3.22 [2.78-3.72] 1.46 [1.18-1.80] 0.45 [0.35-0.59] 0.50 [0.39-0.65] 
Mental disorders and health problems       
   Anxiety 24.03 [22.65-25.46] 26.37 [24.95-27.84] 32.37 [30.81-33.98] 31.94 [30.4-33.53] 0.99 [0.92-1.06] 1.16 [1.07-1.24] 
   Depression 6.90 [6.20-7.66] 7.05 [6.35-7.80] 7.60 [6.88-8.37] 6.21 [5.58-6.90] 0.82 [0.71-0.95] 0.86 [0.74-1.00] 
   Alcohol use disorder 1.32 [1.04-1.66] 1.54 [1.23-1.89] 1.78 [1.45-2.15] 0.84 [0.62-1.10] 0.47 [0.33-0.66] 0.54 [0.38-0.77] 
   Violence against women¶ 1.05 [0.73-1.46] 0.78 [0.52-1.14] 0.89 [0.60-1.26] 0.91 [0.63-1.28] 1.03 [0.61-1.74] 1.01 [0.60-1.70] 
Cancer diseases       
   Breast cancer¶ 3.61 [2.98-4.32] 2.68 [2.15-3.29] 3.11 [2.54-3.76] 2.44 [1.95-3.01] 0.78 [0.58-1.05] 0.78 [0.58-1.05] 
   Colon cancer 0.65 [0.46-0.90] 0.96 [0.72-1.24] 0.65 [0.47-0.89] 0.68 [0.50-0.92] 1.05 [0.66-1.66] 0.91 [0.58-1.41] 
   Benign tumors of the colon 5.76 [5.14-6.42] 7.06 [6.39-7.78] 5.27 [4.70-5.89] 3.51 [3.05-4.01] 0.67 [0.56-0.80] 0.58 [0.49-0.69] 
   Prostate cancer§ 3.25 [2.56-4.08] 3.12 [2.45-3.91] 2.88 [2.25-3.64] 2.26 [1.72-2.91] 0.78 [0.54-1.12] 0.73 [0.51-1.05] 
   Lung cancer 0.55 [0.37-0.77] 0.43 [0.28-0.63] 0.60 [0.42-0.83] 0.74 [0.55-0.99] 1.24 [0.79-1.97] 1.42 [0.88-2.32] 
   Bladder cancer 0.69 [0.49-0.94] 0.75 [0.55-1.01] 0.87 [0.65-1.14] 0.67 [0.48-0.90] 0.77 [0.50-1.17] 0.87 [0.55-1.35] 
   Liver cancer 0.09 [0.03-0.20] 0.20 [0.11-0.36] 0.08 [0.03-0.19] 0.11 [0.04-0.23] 1.33 [0.36-5.31] 0.88 [0.27-2.89] 
   Thyroid cancer 0.33 [0.20-0.52] 0.12 [0.05-0.25] 0.32 [0.19-0.49] 0.09 [0.03-0.21] 0.30 [0.10-0.78] 0.37 [0.12-1.01] 
   Melanoma 0.69 [0.49-0.94] 0.68 [0.49-0.93] 0.80 [0.59-1.06] 0.40[0.26-0.59] 0.49 [0.29-0.82] 0.55 [0.32-0.92] 
   Stomach cancer 0.12 [0.05-0.25] 0.07 [0.02-0.17] 0.13 [0.06-0.26] 0.11 [0.04-0.23] 0.83 [0.26-2.62] 1.02 [0.30-3.59] 
   Kidney cancer 0.46 [0.30-0.67] 0.32 [0.19-0.50] 0.57 [0.39-0.79] 0.27 [0.16-0.43] 0.47 [0.25-0.87] 0.60 [0.31-1.14] 
   Lymphoma/Leukemia 0.11 [0.04-0.23] 0.10 [0.04-0.22] 0.13 [0.06-0.26] 0.17 [0.09-0.31] 1.30 [0.48-3.74] 1.53 [0.53-4.76] 
Values are represented as incidence rates (95% confidence intervals) from to 2017 to 2020.     
In bold, statistically significant (p<0.05) incidence rate ratios.      
† Incidence rate ratios (IRRs) for incidence rates in 2020 compared with incidence rates in 2019     
‡ Incidence rate ratios (IRRs) for incidence rates in 2020 compared with mean incidence rates from 2017 to 2019    
¶ Incidence rates in women       
§ Incidence rates in men       
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Figure 1. Incidence rates of selected conditions from 2017 to 2020. Thick lines show statistical 
significance. 
 
 
